Abstract:To investigate whether Interleukin-13(IL13) and leukotriene D_4 can enhance the expression of cystein leukotriene 1 receptor(CysLT1R) and the production of eotaxin on human lung fibroblasts.Human fetal lung fibroblasts(MRC-5) were cultured and stimultaed with different dose of IL-13,then the expression of CysLT1R in MRC-5 was investigated by quantitative real-time PCR.After stimulated by IL-13 or/and LTD_4,the concentration of eotaxin in the cell supernatant fluid from MRC-5 were measured eotaxin was observed.It was found that only a low level of CysLT1R mRNA was expressed in unstimulated MRC-5,in contrast,stimulated with IL-13 at a concentration of 10 ng/ml fro 48 h,the expression CysLT1R mRNA was 18.56±7.41 times higher than that of unstimulated cells.When stimulated with 100 ng/ml IL-13,it was 20.11±5.05 times higher than unstimulated cells.IL13 also enhanced the production of eotaxin,in which stimulated with 10 ng/ml or 100 ng.ml IL-13,the concentration of eotaxin produced by MRC-5 was(155.43±15.95) pg/ml or(221.31±17.23) pg/ml,which were significantly higher than that of unstimulated cell(P<0.01).LTD_4 singly stimulating MRC-5 didn't enhance the production of eotaxin.However when 10~(-7)mol/L or 10~(-6) mol/L LTD_4 and 10 ng/ml IL-13 together stimulated MRC-5,the concentration of eotaxin was(204.4±25.4) pg/ml or(255.1±38.3) pg/ml,which was significantly higher than that of stimulated with only 10 ng/ml IL-13.MRC-5 in the group of LTD_4 and IL-13 stimulated was incubated with Montelukast,the eotaxin was(148.3±15.7) pg/ml,which was significantly lower than that without Montelukast.These results suggested that there be low expression of CysLT1R mRNA in human lung fibralasts.IL-13 can upregulated the expression of CysLT1R in a time-and dose-dependent manner.There is synergistic effect of LTD_4 and IL-13 on eotaxin production of fibroblasts,which can be abolished by Montelukast.This effect may be due to upregulatioin of CysLT1R expression by IL-13.

Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells]

Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells]

[Effects of leukotriene D4 on proliferation and migration of lung epithelial A549 cells in vitro].

Cysteinyl Leukotriene Receptor 1 Mediates Ltd4-Induced Activation of Mouse Microglial Cells in Vitro

[Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons].

Pranlukast Reduces Neutrophil but Not Macrophage/microglial Accumulation in Brain after Focal Cerebral Ischemia in Mice

Pranlukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, Protects Against Chronic Ischemic Brain Injury and Inhibits the Glial Scar Formation in Mice

Alterations of Serum Cathepsins B and L in Pre-Eclampsia

Study on Cysteinyl Leukotriene Receptor Antagonist Depressing Acute Asthma Airway Inflammation

Effects of Cysteinyl Leukotriene Receptors on Phagocytosis of Mouse Microglial Cells

Leukotriene D4 Stimulates the Migration but Not Proliferation of Endothelial Cells Mediated by the Cysteinyl Leukotriene CysLT1 Receptor via the Extracellular Signal-Regulated Kinase Pathway

Anlotinib induces neuronal‐like differentiation of neuroblastoma by downregulating CRMP5

Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.

[Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].

Pranlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Protects Mice Against Brain Cold Injury

Chemoprevention of esophageal adenocarcinoma in a rat surgical model by a cysteinyl leukotriene receptor‐1 antagonist

Pranlukast Dose-and Time-Dependently Protects Against Ischemic Neuronal Damage in the Rat Hippocampus

Effect of LTD4 and IL-13 on the expression of CysLT1R and production of eotaxin in human lung fibroblasts

Cysteinyl Leukotriene Receptor 1 is Involved in N -Methyl- D -Aspartate-mediated Neuronal Injury in Mice

Therapeutic Effect of Pranlukast, a Cysteinyl Leukotriene Receptor Antagoist, on Focal Cerebral Ischemia in Mice

[Effect of PR-957 on the Formation of A1 Reactive Astrocytes].